Literature DB >> 16831075

Positron emission tomography in gynecological malignancies.

Rakesh Kumar1, Anil Chauhan, Suman Jana, Simin Dadparvar.   

Abstract

Positron emission tomography (PET) is a functional diagnostic imaging technique. F-18 fluoro-2-deoxy-d-glucose (FDG) is a commonly used radiopharmaceutical that is an analog of glucose. PET with FDG is now the standard of care in initial staging, monitoring the response to the therapy and management of various cancers. There is not sufficient data to support the use of PET in the initial diagnosis of cervical cancer; however, FDG-PET has a role in initial staging in the detection of distant metastases in patients with cervical cancer. PET has limited value in lesion localization in early stages of ovarian cancer, but plays a significant role in identifying recurrent tumors in patients with rising tumor markers. In this article, the clinical application of PET in gynecological malignancies is reviewed.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16831075     DOI： 10.1586/14737140.6.7.1033

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


  9 in total

1.  Potential role of coregistered photoacoustic and ultrasound imaging in ovarian cancer detection and characterization.

Authors:  Andres Aguirre; Yasaman Ardeshirpour; Mary M Sanders; Molly Brewer; Quing Zhu
Journal:  Transl Oncol       Date:  2011-02-01       Impact factor: 4.243

2.  A novel dynamic field-matching technique for treatment of patients with para-aortic node-positive cervical cancer: Clinical experience.

Authors:  Craig Baden; Alexander Whitley; Javier López-Araujo; Richard Popple; Jun Duan; Robert Kim
Journal:  Rep Pract Oncol Radiother       Date:  2015-11-21

3.  Interlaced photoacoustic and ultrasound imaging system with real-time coregistration for ovarian tissue characterization.

Authors:  Umar Alqasemi; Hai Li; Guangqian Yuan; Patrick Kumavor; Saeid Zanganeh; Quing Zhu
Journal:  J Biomed Opt       Date:  2014       Impact factor: 3.170

4.  18F-FDG PET/CT evaluation of patients with ovarian carcinoma.

Authors:  Andrei H Iagaru; Erik S Mittra; Iain Ross McDougall; Andrew Quon; Sanjiv Sam Gambhir
Journal:  Nucl Med Commun       Date:  2008-12       Impact factor: 1.690

5.  Recognition algorithm for assisting ovarian cancer diagnosis from coregistered ultrasound and photoacoustic images: ex vivo study.

Authors:  Umar Alqasemi; Patrick Kumavor; Andres Aguirre; Quing Zhu
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

6.  The role of PET/CT in decreasing inter-observer variability in treatment planning and evaluation of response for cervical cancer.

Authors:  Ajay Tejwani; Amir Lavaf; Kapila Parikh; Bahaa Mokhtar; Uma Swamy; Joana Emmolo; Adel Guirguis; Hani Ashamalla
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

7.  Diagnostic, therapeutic and evolutionary characteristics of cervical cancer in Department of Radiotherapy, Mohamed V Military Hospital - Rabat in Morocco.

Authors:  Mohammed Elmarjany; Abdelhak Maghous; Rachid Razine; Elamin Marnouche; Khalid Andaloussi; Amine Bazine; Issam Lalya; Noha Zaghba; Khalid Hadadi; Hassan Sifat; Baba Habib; Jaouad Kouach; Hamid Mansouri
Journal:  Gynecol Oncol Res Pract       Date:  2015-07-27

8.  Cervical lymphadenopathy - an unusual presentation of carcinoma of the cervix: a case report.

Authors:  Madhavi Manoharan; Durga Satyanarayana; Arjun R Jeyarajah
Journal:  J Med Case Rep       Date:  2008-07-28

9.  Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol PET.

Authors:  Yoshio Yoshida; Tetsuji Kurokawa; Tetuya Tsujikawa; Hidehiko Okazawa; Fumikazu Kotsuji
Journal:  J Ovarian Res       Date:  2009-06-16       Impact factor: 4.234
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.